Respiri Limited, formerly Isonea Limited, is engaged in the research, development and commercialization of medical devices, and the production of mobile health applications. The Company's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The Company's devices and applications use digital wheeze detection and measurement technology. The Company's acoustic respiratory monitoring (ARM) technology records airway sounds to detect continuous adventitious breath sounds (CABS), and measures the extent of wheezing caused by airway obstruction. The Company's products include AirSonea, SonoSentry, Wholter and PulmoTrack Computerised Wheeze Detection.